Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966

Neurofibromatosis type 1 is a relatively common genetic disease, with a prevalence ranging between 1/3000 and 1/6000 people worldwide. The disease affects multiple systems with cutaneous, neurologic, and orthopedic as major manifestations which lead to significant morbidity or mortality. Indeed, NF1...

Full description

Saved in:

Bibliographic Details
Published in:	Orphanet journal of rare diseases Vol. 15; no. 1; pp. 37 - 23
Main Authors:	Bergqvist, Christina, Servy, Amandine, Valeyrie-Allanore, Laurence, Ferkal, Salah, Combemale, Patrick, Wolkenstein, Pierre
Format:	Journal Article
Language:	English
Published:	London BioMed Central 03.02.2020 BioMed Central Ltd Springer Nature B.V BMC
Subjects:	Adult Age Canada Care and treatment Child Dermatology Diagnosis Disease management Diseases Experts Families & family life Family medical history Genetic counseling Genetic disorders Genotype & phenotype Glioma Gliomas Guidelines Health aspects Health care Health planning Human Genetics Human health and pathology Humans Life expectancy Life Sciences Life span Literature reviews Malignancy Management Medical care quality Medical diagnosis Medical genetics Medical personnel Medical research Medical treatment Medicine Medicine & Public Health Morbidity Mortality Multidisciplinary Mutation Neurofibromatosis Neurofibromatosis 1 - diagnosis Neurofibromatosis type 1 Neurological disorders Other Patients Pharmacology/Toxicology Position Statement Rare diseases Recklinghausen's disease Skin Studies Tumors Canada France Dermatology Oncology Optic glioma Neurofibromatosis type 1 Management Guidelines Quality of life Neurology Genetic counseling Orthopedics Malignant peripheral nerve sheath tumors Diagnosis Multidisciplinary
ISSN:	1750-1172, 1750-1172
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!